We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Issues Guideline on Biologic Production Changes
EMEA Issues Guideline on Biologic Production Changes
August 6, 2007
A new European Medicines Agency (EMEA) draft guideline details factors taken into consideration when the agency determines whether clinical studies are nessessary to evaluate a biologic drug product after its manufacturing process has changed.